Within the Interstitial Lung Diseases (ILD), patients with idiopathic pulmonary fibrosis (IPF) and a subset of those with non-IPF fibrotic ILD have a distinct clinical phenotype of progression despite
N6-methyladenosine (m6A) modification plays a pivotal role in post-transcriptionally regulating gene expression and biological functions. Nonetheless, the roles of m6A modification in the regulation o
List of mRNA gene expression in SSc-ILD compared to healthy controls. In sequence: gene symbol, gene name, and average fold-change expression in SSc-ILD compared to healthy controls. (XLSX 15Â kb)
